In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
Maximum benefits develop over 3-6 months
Sleep quality and stress physiology play a role, too
TB-500 addresses inflammation through microRNA-146a upregulation, a mechanism entirely separate from Retatrutides metabolic pathways
It may result in redness, irritation, and even collagen breakdown
Drawing 15 units is considerably easier than drawing 5 units